Pathology of Epstein-Barr virus-related lymphomas in HIV

Published: May 29, 2009
Abstract Views: 661
PDF: 719
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Acquired immunodeficiency syndrome-related non-Hodgkin lymphomas (AIDS-NHL) represent a significant source of morbidity and mortality among HIV-infected individuals.1 According to body location and histologic criteria, the pathologic spectrum of AIDS-NHL includes systemic AIDS-NHL, primary central nervous system lymphoma (AIDS-PCNSL), plasmablastic lymphoma of the oral cavity (AIDS-PBL) and primary effusion lymphoma (AIDS-PEL).2 Systemic AIDS-NHL are histologically classified into AIDS-related Burkitt lymphoma (AIDS-BL) and AIDS-related diffuse large B-cell lymphoma (AIDS-DLBCL). All AIDS-PCNSL are histologically represented by DLBCL. Despite their clinico-pathologic heterogeneity, most AIDS-NHL derive from B-cells that have experienced the germinal center (GC) reaction3 and, therefore, have been exposed to the mechanism of somatic hypermutation (SHM) which normally targets the immunoglobulin variable region (IgV).

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Larocca, L. M. (2009). Pathology of Epstein-Barr virus-related lymphomas in HIV. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.248